CVac™
CVac™ therapy is a novel investigational vaccine therapy for the treatment of ovarian cancer. The vaccine therapy uses special cells called dendritic cells taken from the ovarian cancer patient's blood by a process called leukapheresis. The patient’s blood is circulated through a special filter that takes out only the dendritic cells needed to make the vaccine. These cells are matured in the laboratory, and then bathed with a protein called mucin-1 which is present in great amounts in the patient’s tumors cells. The dendritic cells take up the mucin-1, and are then frozen to be shipped to the physician for administration to the patient. The vaccine is thawed and then injected into the surface of the skin. Once in the skin the dendritic cells activate immune cells called T Cells and program them to find and destroy tumour cells producing the mucin-1 protein.
|
|